Providing the sales team with necessary technical expertise, promotional materials, product training, and relevant clinical papers
Reviewing product data to keep the field force updated on new developments and competitor products
Serving as the primary point of contact for all product-related inquiries
Conducting market research to assess customer attitudes and guide new product introductions
Developing annual marketing plans and controlling advertising, promotion, and sales aids
Actively engage with multiple stakeholders in order to foster gathering of insights.
Support implementation of Marketing-led initiatives including supporting and coordinating for appropriate campaign content, support for kick-off or cycle meeting and digital campaigns.
Share in-field best practices and support field teams in their tactical execution for activities.
Supporting marketing colleagues in development of Marketing materials and other marketing inputs.
Preparing product forecasts and monitoring inventory levels to ensure supply chain efficiency
Founded in 1978 in Hyderabad, India, Gland Pharma has evolved from a contract manufacturer of small-volume liquid parenterals into one of the world’s leading and fastest-growing producers of generic injectables, serving over 60 countries, including the US, Europe, Canada, Australia, and India.
Operating under a primarily B2B model, Gland Pharma has built a strong reputation for excellence in R&D, manufacturing, and marketing of complex injectable pharmaceuticals.
Our end-to-end presence in the pharmaceutical value chain has fueled our rapid and sustained growth over the years.
Gland Pharma boasts a professional leadership team, with Shanghai Fosun Pharma, a major global pharmaceutical company, as one of its key promoters.
Our core therapeutic areas include sterile injectables, oncology, and ophthalmology, with a focus on complex formulations such as NCE-1s, First-to-File products, and 505(b)(2) applications.
We currently offer our injectables in various formats, including liquid and lyophilized vials, pre-filled syringes, ampoules, infusion bags, and eye drops.
To expand our capabilities, we are actively investing in the development of advanced formulations, including peptides, long-acting injectables, hormonal products, and suspensions.
As part of our pipeline expansion, we are also introducing innovative delivery systems like pens and cartridges to better meet diverse patient needs.
